These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

258 related items for PubMed ID: 8988452

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effects of trazodone and fluoxetine in the treatment of major depression: therapeutic pharmacokinetic and pharmacodynamic interactions through formation of meta-chlorophenylpiperazine.
    Maes M, Westenberg H, Vandoolaeghe E, Demedts P, Wauters A, Neels H, Meltzer HY.
    J Clin Psychopharmacol; 1997 Oct; 17(5):358-64. PubMed ID: 9315986
    [Abstract] [Full Text] [Related]

  • 3. Lower total serum protein, albumin, and beta- and gamma-globulin in major and treatment-resistant depression: effects of antidepressant treatments.
    Van Hunsel F, Wauters A, Vandoolaeghe E, Neels H, Demedts P, Maes M.
    Psychiatry Res; 1996 Dec 20; 65(3):159-69. PubMed ID: 9029664
    [Abstract] [Full Text] [Related]

  • 4. Can we really accelerate and enhance the selective serotonin reuptake inhibitor antidepressant effect? A randomized clinical trial and a meta-analysis of pindolol in nonresistant depression.
    Portella MJ, de Diego-Adeliño J, Ballesteros J, Puigdemont D, Oller S, Santos B, Álvarez E, Artigas F, Pérez V.
    J Clin Psychiatry; 2011 Jul 20; 72(7):962-9. PubMed ID: 21034693
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Fast onset: an open study of the treatment of major depressive disorder with nefazodone and pindolol combination therapy.
    Bakish D, Hooper CL, Thornton MD, Wiens A, Miller CA, Thibaudeau CA.
    Int Clin Psychopharmacol; 1997 Mar 20; 12(2):91-7. PubMed ID: 9219044
    [Abstract] [Full Text] [Related]

  • 7. Randomised, double-blind, placebo-controlled trial of pindolol in combination with fluoxetine antidepressant treatment.
    Pérez V, Gilaberte I, Faries D, Alvarez E, Artigas F.
    Lancet; 1997 May 31; 349(9065):1594-7. PubMed ID: 9174562
    [Abstract] [Full Text] [Related]

  • 8. Pindolol augmentation in depressed patients resistant to selective serotonin reuptake inhibitors: a double-blind, randomized, controlled trial.
    Perry EB, Berman RM, Sanacora G, Anand A, Lynch-Colonese K, Charney DS.
    J Clin Psychiatry; 2004 Feb 31; 65(2):238-43. PubMed ID: 15003079
    [Abstract] [Full Text] [Related]

  • 9. [Interest of the use of pindolol in the treatment of depression: review].
    Brousse G, Schmitt A, Chereau I, Eschalier A, Dubray C, Llorca PM.
    Encephale; 2003 Feb 31; 29(4 Pt 1):338-50. PubMed ID: 14615704
    [Abstract] [Full Text] [Related]

  • 10. A double-blind, randomized, placebo-controlled trial of pindolol augmentation in depressive patients resistant to serotonin reuptake inhibitors. Grup de Recerca en Trastorns Afectius.
    Pérez V, Soler J, Puigdemont D, Alvarez E, Artigas F.
    Arch Gen Psychiatry; 1999 Apr 31; 56(4):375-9. PubMed ID: 10197835
    [Abstract] [Full Text] [Related]

  • 11. Fluoxetine versus trazodone in the treatment of outpatients with major depression.
    Debus JR, Rush AJ, Himmel C, Tyler D, Polatin P, Weissenburger J.
    J Clin Psychiatry; 1988 Nov 31; 49(11):422-6. PubMed ID: 3053668
    [Abstract] [Full Text] [Related]

  • 12. The use of pindolol with fluoxetine in the treatment of major depression: final results from a double-blind, placebo-controlled trial.
    Berman RM, Anand A, Cappiello A, Miller HL, Hu XS, Oren DA, Charney DS.
    Biol Psychiatry; 1999 May 01; 45(9):1170-7. PubMed ID: 10331109
    [Abstract] [Full Text] [Related]

  • 13. Cost-effectiveness of fluoxetine plus pindolol in patients with major depressive disorder: results from a randomized, double-blind clinical trial.
    Sacristán JA, Gilaberte I, Boto B, Buesching DP, Obenchain RL, Demitrack M, Pérez Sola V, Alvarez E, Artigas F.
    Int Clin Psychopharmacol; 2000 Mar 01; 15(2):107-13. PubMed ID: 10759342
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Pindolol augmentation enhances response outcomes in first depressive episodes.
    Portella MJ, de Diego-Adeliño J, Puigdemont D, Pérez-Egea R, Alvarez E, Artigas F, Pérez V.
    Eur Neuropsychopharmacol; 2009 Jul 01; 19(7):516-9. PubMed ID: 19419845
    [Abstract] [Full Text] [Related]

  • 16. Effect of pindolol in hastening response to fluoxetine in the treatment of major depression: a double-blind, placebo-controlled trial.
    Berman RM, Darnell AM, Miller HL, Anand A, Charney DS.
    Am J Psychiatry; 1997 Jan 01; 154(1):37-43. PubMed ID: 8988956
    [Abstract] [Full Text] [Related]

  • 17. How long should pindolol be associated with paroxetine to improve the antidepressant response?
    Zanardi R, Artigas F, Franchini L, Sforzini L, Gasperini M, Smeraldi E, Perez J.
    J Clin Psychopharmacol; 1997 Dec 01; 17(6):446-50. PubMed ID: 9408806
    [Abstract] [Full Text] [Related]

  • 18. A comparative, randomized, double-blind study of trazodone prolonged-release and sertraline in the treatment of major depressive disorder.
    Munizza C, Olivieri L, Di Loreto G, Dionisio P.
    Curr Med Res Opin; 2006 Sep 01; 22(9):1703-13. PubMed ID: 16968574
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Intravenous administration of adenosine triphosphate and phosphocreatine combined with fluoxetine in major depressive disorder: protocol for a randomized, double-blind, placebo-controlled pilot study.
    Chen Y, Cao X, Zang W, Tan S, Ou CQ, Shen X, Gao T, Zhao L.
    Trials; 2019 Jan 09; 20(1):34. PubMed ID: 30626424
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.